Target intelligence / Profile preview

Protein synthesis quality control system (PSQC)

Target
PSQC
Molecular classification
Enzyme, Chaperone, Ribosome, E3 ubiquitin ligase, Proteasome, RNA-binding protein
01

Overview

The protein synthesis quality control (PSQC) system is a multi-layered network of cellular pathways responsible for maintaining the integrity of the proteome by monitoring protein production, folding, and degradation (Balch et al., 2008, Science). It includes ribosome-associated quality control (RQC), which detects stalled translation and targets nascent chains for degradation, and the unfolded protein response (UPR), which manages protein folding stress in the endoplasmic reticulum (Brandman & Hegde, 2016, Nat Rev Mol Cell Biol; Walter & Ron, 2011, Science). These pathways utilize molecular chaperones to facilitate folding and the ubiquitin-proteasome system (UPS) or autophagy to eliminate defective proteins. Failure of the PSQC leads to the accumulation of misfolded proteins and aggregates, a primary driver of neurodegenerative diseases such as Alzheimer's and Parkinson's (Hipp et al., 2019, Nat Rev Mol Cell Biol). Conversely, cancer cells often upregulate PSQC components to survive high levels of protein synthesis and mutation-induced stress, making these pathways attractive targets for chemotherapy. Drugs like bortezomib target the proteasome, while others target chaperones like Hsp90 or UPR sensors like PERK to disrupt proteostasis in diseased cells (Deshaies, 2014, Nature).

Other names
Proteostasis networkProtein quality controlPQCRibosome-associated quality controlRQCmRNA surveillanceEndoplasmic reticulum-associated degradationERADUnfolded protein responseUPR
02

Mechanism of action

Modulation of protein folding, degradation, and translation fidelity through inhibition or activation of specific nodes such as the proteasome, molecular chaperones, or the unfolded protein response (UPR) sensors.

03

Biological functions

Protein foldingProtein degradationTranslation regulationmRNA surveillanceStress responseProteostasisAutophagy
04

Disease associations

Neurodegenerative diseaseCancerCystic fibrosisPrion diseaseAmyloidosisMetabolic disorder
05

Safety considerations

Systemic toxicityPeripheral neuropathyProteotoxicityNarrow therapeutic indexOff-target effects on healthy proteostasis
06

Interacting drugs

Bortezomib

8 more in the full profile.

07

Biomarkers

Ubiquitinated proteinsHsp70XBP1s (spliced XBP1)ATF4CHOPp-eIF2alpha

Beyond the preview

Go deeper on Protein synthesis quality control system (PSQC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein synthesis quality control system (PSQC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call